1. Home
  2. AEHL vs BJDX Comparison

AEHL vs BJDX Comparison

Compare AEHL & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AEHL

Antelope Enterprise Holdings Limited

HOLD

Current Price

$3.00

Market Cap

8.4M

Sector

Industrials

ML Signal

HOLD

Logo Bluejay Diagnostics Inc.

BJDX

Bluejay Diagnostics Inc.

HOLD

Current Price

$1.08

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHL
BJDX
Founded
1993
2015
Country
China
United States
Employees
N/A
N/A
Industry
Building Materials
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
2.2M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
AEHL
BJDX
Price
$3.00
$1.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.0M
111.2K
Earning Date
12-26-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$98,773,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$55.56
P/E Ratio
N/A
N/A
Revenue Growth
36.99
N/A
52 Week Low
$1.13
$1.04
52 Week High
$11.53
$10.20

Technical Indicators

Market Signals
Indicator
AEHL
BJDX
Relative Strength Index (RSI) 58.22 30.14
Support Level $2.88 $1.13
Resistance Level $3.21 $1.30
Average True Range (ATR) 0.56 0.10
MACD 0.05 0.00
Stochastic Oscillator 66.35 3.61

Price Performance

Historical Comparison
AEHL
BJDX

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.

Share on Social Networks: